Exact Mass: 319.9698
Exact Mass Matches: 319.9698
Found 134 metabolites which its exact mass value is equals to given mass value 319.9698,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
lorazepam
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics CONFIDENCE standard compound; INTERNAL_ID 1512 CONFIDENCE standard compound; INTERNAL_ID 8600 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3138
Lorazepam
Lorazepam is only found in individuals that have used or taken this drug. It is a benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent. [PubChem]Lorazepam binds to an allosteric site on GABA-A receptors, which are pentameric ionotropic receptors in the CNS. Binding potentiates the effects of the inhibitory neurotransmitter GABA, which upon binding opens the chloride channel in the receptor, allowing chloride influx and causing hyperpolerization of the neuron. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics
3-Alizarinsulfonic acid
D004396 - Coloring Agents
Benzolamide
D004791 - Enzyme Inhibitors > D002257 - Carbonic Anhydrase Inhibitors C471 - Enzyme Inhibitor > C29577 - Carbonic Anhydrase Inhibitor
Lonidamine
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent D009676 - Noxae > D000988 - Antispermatogenic Agents D011838 - Radiation-Sensitizing Agents C1744 - Multidrug Resistance Modulator D000970 - Antineoplastic Agents Lonidamine (AF-1890) is a hexokinase and mitochondrial pyruvate carrier inhibitor (Ki: 2.5 μM). Lonidamine also inhibits aerobic glycolysis in cancer cells. Lonidamine can be used in the research of mitochondrial metabolism and inflammation, such as pulmonary fibrosis[1][2][3].
(2Z)-6-Bromo-3-chloromethyl-1,7-dichloro-7-methylocta-2-ene
3-Chloro-1, 2, 4, 5-tetrahydroxy-7-methylanthraquinone
Ellagic acid hydrate
Lonidamine
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent D009676 - Noxae > D000988 - Antispermatogenic Agents D011838 - Radiation-Sensitizing Agents C1744 - Multidrug Resistance Modulator D000970 - Antineoplastic Agents Lonidamine (AF-1890) is a hexokinase and mitochondrial pyruvate carrier inhibitor (Ki: 2.5 μM). Lonidamine also inhibits aerobic glycolysis in cancer cells. Lonidamine can be used in the research of mitochondrial metabolism and inflammation, such as pulmonary fibrosis[1][2][3].
2-chloro-1,3,8-trihydroxy-6-(hydroxymethyl)anthracene-9,10-dione
2-chloro-1,3,8-trihydroxy-6-(hydroxymethyl)anthracene-9,10-dione_major
1-(5-BROMO-1H-INDOL-3-YL)-2-(PYRROLIDIN-1-YL)ETHANE-1,2-DIONE
Diethyl2,6-dimercapto-4-oxo-4H-thiopyran-3,5-dicarboxylate
3-(5-Bromo-2-hydroxyphenyl)-3-phenylpropanoic acid
5-Amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile
Potassium 3,5-bis(trifluoromethyl)phenytrifluoroborate
7-chloro 5-(2-chlorophenyl)-1,3-dihydro-2H-(1,4)-benzodiazepine-2-thione
3-(TRIFLUOROMETHYL)[1,1-BIPHENYL]-4-SULFONYL CHLORIDE
2-(5,6-dihydro-[1,3]dithiolo[4,5-b][1,4]dioxin-2-ylidene)-5,6-dihydro-[1,3]dithiolo[4,5-b][1,4]dioxine
2-CHLORO-3-(4-IODO-5-METHYL-[1,2,3]TRIAZOL-1-YL)-PYRIDINE
4-Chloro-1-((3-(trifluoromethyl)phenoxy)Methyl)-1H-pyrazole-3-carboxylic acid
7-chloro-5-(2-chlorophenyl)-1,3-dihydro-2H-benzo-1,4-diazepin-2-one 4-oxide
Tenidap
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors
Methyl 5-fluoro-6-iodo-1H-pyrrolo[2,3-b]pyridine-4-carboxylate
4-(TRIFLUOROMETHYL)-[1,1-BIPHENYL]-4-SULFONYL CHLORIDE
2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]acetic acid
1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXALDEHYDE, 5-CHLORO-1-(PHENYLSULFONYL)-
1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXALDEHYDE, 4-CHLORO-1-(PHENYLSULFONYL)-
2-(4-Bromophenyl)-1-(2-hydroxy-4-methoxyphenyl)ethanone
(2-IODO-PYRIDIN-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER
2-[(4,6-Dichloro-1,3,5-triazin-2-yl)amino]benzenesulfonic acid
2,3-Dihydro-5-chloro-2-oxo-3-(2-thienylcarbonyl)-1H-indole-1-carboxamide
3-Bromo-2,2-dimethyl-3,4-dihydro-2H-benzo(h)chromene-5,6-dione
1H-Indazole-3-carboxylic acid, 1-(3,4-dichlorobenzyl)-
N-(1,3-benzodioxol-5-yl)-5-bromo-3-pyridinecarboxamide
2-(4,5-dihydrothiazol-2-ylthio)-N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]acetamide
2-Chloro-1,3,8-trihydroxy-6-(hydroxymethyl)anthraquinone
(1-Hydroxy-2-(imidazo(1,2-a)-pyridin-3-yl)ethylidene)bisphosphonic acid monohydrate
D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates
4-fluoro-N-(7-methyl-4-oxo-2-thieno[3,2-d][1,3]thiazinyl)benzamide
3-(5-Bromo-2-furanyl)-5-(4-methoxyphenyl)-1,2,4-oxadiazole
5-O-(1-carboxylatovinyl)-3-phosphonatoshikimate
The conjugate base of 5-O-(1-carboxyvinyl)-3-phosphoshikimic acid. It is an intermediate in the shikimate pathway.
3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid
D004396 - Coloring Agents
